PARP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.625800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.397200E-01
Normal-vs-Stage2
3.652400E-01
Normal-vs-Stage3
4.139800E-01
Normal-vs-Stage4
2.781800E-01
Stage1-vs-Stage2
8.423000E-01
Stage1-vs-Stage3
1.236840E-01
Stage1-vs-Stage4
6.373600E-01
Stage2-vs-Stage3
9.028400E-02
Stage2-vs-Stage4
3.955400E-01
Stage3-vs-Stage4
1.208450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.115200E-01
Normal-vs-AfricanAmerican
3.851600E-01
Normal-vs-Asian
3.383400E-01
Caucasian-vs-AfricanAmerican
5.923400E-01
Caucasian-vs-Asian
4.381400E-01
AfricanAmerican-vs-Asian
9.716200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.154400E-01
Normal-vs-Female
5.382400E-01
Male-vs-Female
5.027200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.648000E-01
Normal-vs-Age(41-60Yrs)
3.497600E-01
Normal-vs-Age(61-80Yrs)
5.482000E-01
Normal-vs-Age(81-100Yrs)
4.017800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.681600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.130400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.225000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.081370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.487000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.142000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.037200E-01
Normal-vs-Daily Drinker
7.919200E-01
Normal-vs-Weekly Drinker
6.733600E-01
Normal-vs-Occasional Drinker
3.505600E-01
Normal-vs-Social Drinker
2.894600E-01
Non Drinker-vs-Daily Drinker
7.276000E-01
Non Drinker-vs-Weekly Drinker
9.505400E-01
Non Drinker-vs-Occasional Drinker
1.745800E-01
Non Drinker-vs-Social Drinker
6.550800E-01
Daily Drinker-vs-Weekly Drinker
7.613200E-01
Daily Drinker-vs-Occasional Drinker
1.658810E-01
Daily Drinker-vs-Social Drinker
4.562400E-01
Weekly Drinker-vs-Occasional Drinker
3.473800E-01
Weekly Drinker-vs-Social Drinker
7.850800E-01
Occasional Drinker-vs-Social Drinker
3.497200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.730390E-01
Normal-vs-Grade 2
1.459580E-02
Normal-vs-Grade 3
4.456300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.710040E-02
Grade 1-vs-Grade 3
1.837770E-02
Grade 1-vs-Grade 4
1.730390E-01
Grade 2-vs-Grade 3
5.921800E-01
Grade 2-vs-Grade 4
1.459580E-02
Grade 3-vs-Grade 4
4.456300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.494400E-01
Normal-vs-NonDiabetic
4.603400E-01
Diabetic-vs-NonDiabetic
1.865400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.163600E-01
Normal-vs-NoPancreatitis
5.322200E-01
Pancreatitis-vs-NoPancreatitis
7.478200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.122200E-01
Normal-vs-N1
4.120800E-01
N0-vs-N1
4.894200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.149420E-01
Normal-vs-TP53-NonMutant
5.606000E-01
TP53-Mutant-vs-TP53-NonMutant
4.878300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
